PT-141 (Bremelanotide) is a research-grade synthetic peptide derived from Melanotan II that acts as a melanocortin-receptor agonist. In contrast to PDE5 inhibitors, it operates centrally through the nervous system rather than the vascular system. Supplied for in vitro investigation across melanocortin-receptor pathways, arousal signalling, and neuroendocrine research.
Product Specifications:
- Purity: ≥99% (HPLC Verified)
- Form: Lyophilized Powder
- Unit Size: One vial containing 10mg
- Storage: Store at -20°C or lower
- Usage: Laboratory research use only
Research Applications:
PT-141 is characterised in vitro for its role in:
- Melanocortin receptor (MC1R–MC5R) agonism and pathway modulation
- Central-nervous-system arousal signalling model systems
- Neuroendocrine function and hypothalamic pathway studies
- Peptide-mediated mood and behaviour modulation mechanisms
Note: This product is supplied strictly for in vitro laboratory research use only and is not for human or veterinary use. Misuse may contravene local or federal regulations.
